Quantitative Estimation of Permeability Surface-Area Product in Astroglial Brain Tumors Using Perfusion CT and Correlation with Histopathologic Grade

BACKGROUND AND PURPOSE: Glioma angiogenesis and its different hemodynamic features, which can be evaluated by using perfusion CT (PCT) imaging of the brain, have been correlated with the grade and the aggressiveness of gliomas. Our hypothesis was that quantitative estimation of permeability surface area product (PS), cerebral blood volume (CBV), cerebral blood flow (CBF), and mean transit time (MTT) in astroglial brain tumors by using PCT will correlate with glioma grade. High-grade gliomas will show higher PS and CBV as compared with low-grade gliomas. MATERIALS AND METHODS: PCT was performed in 32 patients with previously untreated astroglial tumors (24 high-grade gliomas and 8 low-grade gliomas) by using a total acquisition time of 170 seconds. World Health Organization (WHO) glioma grades were compared with PCT parameter absolute values by using Student or nonparametric Wilcoxon 2-sample tests. Receiver operating characteristic (ROC) analyses were also done for each of the parameters. RESULTS: The differences in PS, CBV, and CBF between the low- and high-grade tumor groups were statistically significant, with the low-grade group showing lower mean values than the high-grade group. ROC analyses showed that both CBV (C-statistic 0.930) and PS (C-statistic 0.927) were very similar to each other in differentiating low- and high-grade gliomas and had higher predictability compared with CBF and MTT. Within the high-grade group, differentiation of WHO grade III and IV gliomas was also possible by using PCT parameters, and PS showed the highest C-statistic value (0.926) for the ROC analyses in this regard. CONCLUSIONS: Both PS and CBV showed strong association with glioma grading, high-grade gliomas showing higher PS and CBV as compared with low-grade gliomas. Perfusion parameters, especially PS, can also be used to differentiate WHO grade III from grade IV in the high-grade tumor group.

[1]  D M Shames,et al.  Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: comparison of macromolecular and small-molecular contrast media. , 1998, AJR. American journal of roentgenology.

[2]  Ting-Yim Lee,et al.  Quantification of angiogenesis by functional computed tomography in a Matrigel model in rats. , 2004, Academic radiology.

[3]  C. Sarkar,et al.  Angiogenic patterns and their quantitation in high grade astrocytic tumors , 2006, Journal of Neuro-Oncology.

[4]  N. Weidner.  Intratumor microvessel density as a prognostic factor in cancer. , 1995, The American journal of pathology.

[5]  Yue Cao,et al.  Estimate of vascular permeability and cerebral blood volume using Gd‐DTPA contrast enhancement and dynamic T2*‐weighted MRI , 2006, Journal of magnetic resonance imaging : JMRI.

[6]  Michael H Lev,et al.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.

[7]  Robert C Brasch,et al.  Dynamic contrast‐enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti‐angiogenic therapy in a xenograft model of glioblastoma multiforme , 2002, Journal of magnetic resonance imaging : JMRI.

[8]  Xin Li,et al.  A unified magnetic resonance imaging pharmacokinetic theory: Intravascular and extracellular contrast reagents , 2005, Magnetic resonance in medicine.

[9]  J. M. Provenzale,et al.  Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging , 2003, Neuroradiology.

[10]  R K Jain,et al.  Vascular permeability and microcirculation of gliomas and mammary carcinomas transplanted in rat and mouse cranial windows. , 1994, Cancer research.

[11]  T. Conturo,et al.  Mr imaging of cerebral perfusion by phase‐angle reconstruction of bolus paramagnetic‐induced frequency shifts , 1992, Magnetic resonance in medicine.

[12]  T E Conturo,et al.  Contrast‐agent phase effects: An experimental system for analysis of susceptibility, concentration, and bolus input function kinetics , 1997, Magnetic resonance in medicine.

[13]  Wei Huang,et al.  Evidence for shutter‐speed variation in CR bolus‐tracking studies of human pathology , 2005, NMR in biomedicine.

[14]  S. Cha,et al.  Update on brain tumor imaging: from anatomy to physiology. , 2006, AJNR. American journal of neuroradiology.

[15]  A. Maia,et al.  MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. , 2005, AJNR. American journal of neuroradiology.

[16]  Walter H Backes,et al.  Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice. , 2005, Radiology.

[17]  L. K. Hansen,et al.  Defining a local arterial input function for perfusion MRI using independent component analysis , 2004, Magnetic resonance in medicine.

[18]  R K Jain,et al.  Determinants of tumor blood flow: a review. , 1988, Cancer research.

[19]  M. Dewhirst,et al.  The role of blood-brain barrier permeability in brain tumor imaging and therapeutics. , 2005, AJR. American journal of roentgenology.

[20]  E. Akbudak,et al.  Arterial input functions for dynamic susceptibility contrast MRI: Requirements and signal options , 2005, Journal of magnetic resonance imaging : JMRI.

[21]  Alan Jackson,et al.  Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade. , 2002, AJNR. American journal of neuroradiology.

[22]  N. van Bruggen,et al.  Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. , 1998, Cancer investigation.

[23]  Glyn Johnson,et al.  Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. , 2002, Radiology.

[24]  R M Weisskoff,et al.  Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. , 2006, AJNR. American journal of neuroradiology.

[25]  Meiyappan Solaiyappan,et al.  Reduction of vascular and permeable regions in solid tumors detected by macromolecular contrast magnetic resonance imaging after treatment with antiangiogenic agent TNP-470. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  R. Craen,et al.  A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. , 2000, AJNR. American journal of neuroradiology.

[27]  T E Conturo,et al.  Arterial input functions from MR phase imaging , 1996, Magnetic resonance in medicine.

[28]  Xin Li,et al.  Equilibrium transcytolemmal water‐exchange kinetics in skeletal muscle in vivo , 1999, Magnetic resonance in medicine.

[29]  P. Kelly,et al.  Perfusion Magnetic Resonance Imaging Predicts Patient Outcome as an Adjunct to Histopathology: A Second Reference Standard in the Surgical and Nonsurgical Treatment of Low-grade Gliomas , 2006, Neurosurgery.

[30]  Peter Vajkoczy,et al.  Vascular microenvironment in gliomas. , 2004, Cancer treatment and research.

[31]  W. Rooney,et al.  Determination of the MRI contrast agent concentration time course in vivo following bolus injection: Effect of equilibrium transcytolemmal water exchange , 2000, Magnetic resonance in medicine.

[32]  M. Knopp,et al.  Estimating kinetic parameters from dynamic contrast‐enhanced t1‐weighted MRI of a diffusable tracer: Standardized quantities and symbols , 1999, Journal of magnetic resonance imaging : JMRI.

[33]  T. Purdie,et al.  Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. , 2001, Physics in medicine and biology.

[34]  D. Gadian,et al.  Delay and dispersion effects in dynamic susceptibility contrast MRI: Simulations using singular value decomposition , 2000, Magnetic resonance in medicine.

[35]  Ting-Yim Lee,et al.  Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases. , 2002, AJNR. American journal of neuroradiology.

[36]  B R Rosen,et al.  Clinical applications of intracranial perfusion MR imaging. , 1999, Neuroimaging clinics of North America.

[37]  Yan Bo Zhu,et al.  Comparison of cerebral blood volume and permeability in preoperative grading of intracranial glioma using CT perfusion imaging , 2006, Neuroradiology.

[38]  Glyn Johnson,et al.  Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.

[39]  Dai Fukumura,et al.  Dissecting tumour pathophysiology using intravital microscopy , 2002, Nature Reviews Cancer.

[40]  Glyn Johnson,et al.  Measuring blood volume and vascular transfer constant from dynamic, T  2* ‐weighted contrast‐enhanced MRI , 2004, Magnetic resonance in medicine.

[41]  A. Sorensen,et al.  Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. , 2002, AJR. American journal of roentgenology.

[42]  Steve Halligan,et al.  Quantitative Colorectal Cancer Perfusion Measurement Using Dynamic Contrast-Enhanced Multidetector-Row Computed Tomography: Effect of Acquisition Time and Implications for Protocols , 2005, Journal of computer assisted tomography.

[43]  D. Gadian,et al.  Quantification of bolus‐tracking MRI: Improved characterization of the tissue residue function using Tikhonov regularization , 2003, Magnetic resonance in medicine.

[44]  T. Helbich,et al.  Prostate cancer tumor grade differentiation with dynamic contrast-enhanced MR imaging in the rat: comparison of macromolecular and small-molecular contrast media--preliminary experience. , 1999, Radiology.

[45]  Thomas E Yankeelov,et al.  Variation of the relaxographic “shutter‐speed” for transcytolemmal water exchange affects the CR bolus‐tracking curve shape , 2003, Magnetic resonance in medicine.

[46]  R K Jain,et al.  Openings between defective endothelial cells explain tumor vessel leakiness. , 2000, The American journal of pathology.

[47]  T. Mikkelsen,et al.  Role of Perfusion CT in Glioma Grading and Comparison with Conventional MR Imaging Features , 2007, American Journal of Neuroradiology.

[48]  P. Choyke,et al.  Imaging of angiogenesis: from microscope to clinic , 2003, Nature Medicine.

[49]  D M Shames,et al.  Mammary carcinoma model: correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. , 1996, Radiology.

[50]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[51]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[52]  Georg Breier,et al.  Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.

[53]  W P Dillon,et al.  Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. , 2001, Academic radiology.

[54]  T. Mikkelsen,et al.  FIRST‐PASS PERFUSION COMPUTED TOMOGRAPHY: INITIAL EXPERIENCE IN DIFFERENTIATING RECURRENT BRAIN TUMORS FROM RADIATION EFFECTS AND RADIATION NECROSIS , 2007, Neurosurgery.

[55]  C. P. Winlove,et al.  Effects of Perfusion Rate on Permeability of Frog and Rat Mesenteric Microvessels to Sodium Fluorescein , 2002, The Journal of physiology.

[56]  Susan M. Chang,et al.  Dynamic susceptibility-weighted perfusion imaging of high-grade gliomas: characterization of spatial heterogeneity. , 2005, AJNR. American journal of neuroradiology.

[57]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[58]  P. Choyke.  Contrast agents for imaging tumor angiogenesis: is bigger better? , 2005, Radiology.

[59]  M. Maeda,et al.  Double-echo perfusion-weighted MR imaging: basic concepts and application in brain tumors for the assessment of tumor blood volume and vascular permeability , 2005, European Radiology.